Since sEH inhibitors also have anti-inflammatory potential as revealed by previous studies they could be of immense benefit to the patients of CVD because in hypertension and other cardiac ailments there is a definite role of inflammation in the progression of disease19. The gene discussed is EPHX2; the disease is hypertensive disorder.